FDA authorizes Pfizer’s COVID booster dose for children 5-11 years of age

Niños reciben vacuna contra la COVID-19 en EE.UU.

Children receive COVID-19 vaccine in the US

Photo: JEFF KOWALSKY/AFP/Getty Images

The United States Food and Drug Administration (FDA) authorized this Tuesday the use of a booster dose of the Pfizer/BioNTech vaccine against COVID-19 for children between 5 and 11 years of age.

“While it is true that COVID-19 is usually less severe in children than in adults, the Omicron wave has caused more children to get sick and be hospitalized,” FDA Commissioner Robert M. Califf said in a statement.

The doctor also recalled that some of these children may suffer long-term effects, even if they have not had very serious symptoms when infected.

The authorization is based on a study of the immune response of a group of children which already allowed, in October 2021, the approval of the use of the complete schedule of the Pfizer vaccine for this age group.

At the beginning of the year, the FDA already authorized the booster dose for young people between 12 and 15 years of age.

Children under 5 years of age, however, cannot yet be vaccinated against covid.

The country is about to exceed one million deaths from coronavirus: although Johns Hopkins University maintains the figure at 999,842, the US government already considered that number exceeded last Thursday.

“As a nation, we must not become numb to pain. To heal ourselves, we must remember,” US President Joe Biden said at the time.

It may interest you:
– COVID cases on the rise in Los Angeles with more than 4,000 in one day
– The pandemic is not over: the warning from the second global COVID summit
– Joe Biden laments the “tragic milestone” of one million deaths from COVID in the US.

See also  How Attention Deficit Disorder Is Identified

Leave a Comment

Your email address will not be published.